JOHNSON & JOHNSON

(JNJ)
  Report
Delayed Nyse  -  04:00 2022-06-30 pm EDT
177.51 USD   +0.29%
08:22aJanssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Talquetamab for the Treatment of Relapsed or Refractory Multiple Myeloma
AQ
03:45aHywin Holdings, FactSet Launch Global Health Care Index
MT
06/29NHIF, Janssen Kenya Sign MOU to Enhance Prostrate Cancer Drugs Access
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thinking about trading options or stock in Costco, Dollar Tree, Micron, Upstart, or Johnson & Johnson?

05/18/2022 | 10:51am EDT

NEW YORK, May 18, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for COST, DLTR, MU, UPST, and JNJ.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-costco-dollar-tree-micron-upstart-or-johnson--johnson-301550304.html

SOURCE InvestorsObserver


© PRNewswire 2022
All news about JOHNSON & JOHNSON
08:22aJanssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Talquetamab for..
AQ
03:45aHywin Holdings, FactSet Launch Global Health Care Index
MT
06/29NHIF, Janssen Kenya Sign MOU to Enhance Prostrate Cancer Drugs Access
AQ
06/29Johnson & Johnson Unit Secures FDA's Breakthrough Therapy Designation For Talquetamab i..
MT
06/28MeiraGTx Sees Positive Data From Phase 1/2 Trial of Botaretigene Sparoparvovec for X-Li..
MT
06/27Janssen Receives Positive CHMP Opinion for IMBRUVICA (ibrutinib) in a Fixed-Duration Co..
AQ
06/24Johnson & Johnson's Janssen Receives EU Medicines Agency Panel's Backing for Leukemia D..
MT
06/24Johnson & Johnson's Unit Janssen Says EMA's Committee Backs Approval of Imbruvica to Tr..
MT
06/24JOHNSON & JOHNSON'S JANSSEN : CHMP Backs Expanded Imbruvica Use in Chronic Lymphocytic Leu..
DJ
06/23JOHNSON & JOHNSON : Renews Commitment to Fight Neglected Tropical Diseases, Investing in B..
PU
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations